ArticleJournal of molecular histology2026
Downregulation of fibroblast growth factor 7 impairs endometrial receptivity and decidualisation via extracellular signal-regulated kinase and C-Jun N-Terminal kinase pathways, contributing to recurrent spontaneous abortion.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Recurrent spontaneous abortion (RSA) presents a significant reproductive hurdle, impacting 2-5% of women globally. Despite identification of various aetiological factors, approximately half of all cases remain unexplained. In this study, we delve into the critical role of fibroblast growth factor 7 (FGF7) in RSA, particularly in the realm of impaired endometrial receptivity. Leveraging bioinformatic analyses and experimental approaches involving decidual tissues, as well as human endometrial stromal cells (HESCs) and Ishikawa cells culture, we probe into the regulatory patterns of FGF7 and its impact on essential cellular processes pivotal for endometrial function. Our results reveal a correlation between FGF7 downregulation (decreased by approximately 50%, p < 0.05) and disruptions in HESC proliferation and apoptosis, pivotal aspects of RSA pathogenesis. Notably, we delineate the disruptions in decidualisation processes crucial for successful implantation and pregnancy maintenance under FGF7 suppression. These insights deepen our comprehension of the molecular dynamics underlying impaired endometrial receptivity in RSA, potentially guiding the development of targeted therapies. Our study underscores the therapeutic potential of FGF7 modulation, backed by evidence from related studies on its benefits in tissue regeneration and oxidative stress mitigation.
Indexed as
Identifiers
42371162What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.